Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Shift to value-based medicine will boost mHealth uptake

Advances in devices and network coverage will also both contribute, say analysts

mobile health mHealth pharma

The healthcare sector’s shift towards value-based medicine will drive the continued uptake and mainstreaming of mobile health (mHealth) services and solutions.

The use of mHealth will also be led by advances in mobile devices and network coverage, combined with falling prices for wireless technologies, according to GBI Research.

Managing analyst Rodrigo Gutierrez Gamboa said: “These technologies have huge potential to bridge the gap within existing healthcare systems, offering an alternative form of healthcare communication and treatment at a distance.

“As the uptake of mHealth technologies increases, support from healthcare professionals, reimbursement entities and government agencies will also increase as the body of literature documenting the wide range of mHealth’s benefits continues to grow.”

Globally the continued acceleration of mobile penetration will, he added, make mHealth services and solutions possible “even in the most remote areas”.

Key drivers for mHealth uptake outlined in GBI Research’s new Mobile Health (mHealth) Technologies: Global Market Prospects report start with the need for more cost-effective means to deliver healthcare.

That’s followed by followed by an increasing need to demonstrate the value and effectiveness of treatments and to win more support for mHealth solutions from healthcare professionals and reimbursement bodies.

Gutierrez Gamboa added: “These three factors are directly linked to the significant challenge governments in all key markets are facing regarding the rising cost of providing healthcare.

“Insurance companies and national healthcare agencies are increasingly demanding more evidence for the cost-effectiveness of treatments. mHealth technologies can significantly lower the cost of healthcare, starting with the ability to provide medical consultations at a distance.”

23rd June 2017

From: Healthcare

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

Pandemic preparedness
The pandemic preparedness paradox
Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...

Infographics